Delta Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$2.55M Buy
97,540
+882
+0.9% +$23.1K 0.58% 32
2024
Q4
$2.56M Buy
+96,658
New +$2.62M 0.6% 28
2024
Q2
Sell
-101,791
Closed -$2.83M 199
2024
Q1
$2.83M Sell
101,791
-321
-0.3% -$8.91K 0.83% 22
2023
Q4
$2.94M Sell
102,112
-1,966
-2% -$59.4K 0.92% 16
2023
Q3
$3.45M Buy
+104,078
New +$3.68M 1.19% 12
2023
Q2
Sell
-105,080
Closed -$4.29M 163
2023
Q1
$4.29M Buy
105,080
+2,953
+3% +$128K 1.68% 8
2022
Q4
$5.22M Buy
+102,127
New +$4.9M 2.31% 5

Other funds holding PFE

Delta Financial Group's PFE Position: Q1 2025 in Review

Delta Financial Group increased its Pfizer (PFE) stake by 0.91% in Q1 2025, buying an estimated $23.1K and bringing the position to 97,540 shares worth $2.55M. The position accounts for 0.58% of the portfolio, ranked #32.

Delta Financial Group first reported a position in PFE in Q4 2022 and has held it in 7 quarters since. The position peaked at $5.22M in Q4 2022. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • Delta Financial Group held 97,540 shares of Pfizer worth $2.55M as of Q1 2025.
  • Delta Financial Group bought 882 Pfizer shares in Q1 2025, an estimated $23.1K.
  • Pfizer made up 0.58% of Delta Financial Group's portfolio in Q1 2025, its #32 holding.
  • Delta Financial Group first reported a position in Pfizer in Q4 2022 and has held it in 7 quarters since.
  • Delta Financial Group's Pfizer position peaked at $5.22M in Q4 2022.
  • 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Delta Financial Group's 13F filing for Q1 2025, filed 9 May 2025.